TY - JOUR AU - Cerundolo, V. PY - 2009 DA - 2009// TI - Harnessing invariant NKT cells in vaccination strategies JO - Nat Rev Immunol VL - 9 UR - https://doi.org/10.1038/nri2451 DO - 10.1038/nri2451 ID - Cerundolo2009 ER - TY - JOUR AU - Godfrey, D. I. PY - 2004 DA - 2004// TI - NKT cells: what’s in a name? JO - Nat Rev Immunol VL - 4 UR - https://doi.org/10.1038/nri1309 DO - 10.1038/nri1309 ID - Godfrey2004 ER - TY - JOUR AU - Cardell, S. PY - 1995 DA - 1995// TI - CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice JO - J Exp Med VL - 182 UR - https://doi.org/10.1084/jem.182.4.993 DO - 10.1084/jem.182.4.993 ID - Cardell1995 ER - TY - JOUR AU - Behar, S. M. PY - 1999 DA - 1999// TI - Diverse TCRs recognize murine CD1 JO - J Immunol VL - 162 ID - Behar1999 ER - TY - JOUR AU - Bendelac, A. AU - Savage, P. B. AU - Teyton, L. PY - 2007 DA - 2007// TI - The biology of NKT cells JO - Annu Rev Immunol VL - 25 UR - https://doi.org/10.1146/annurev.immunol.25.022106.141711 DO - 10.1146/annurev.immunol.25.022106.141711 ID - Bendelac2007 ER - TY - JOUR AU - Borg, N. A. PY - 2007 DA - 2007// TI - CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor JO - Nature VL - 448 UR - https://doi.org/10.1038/nature05907 DO - 10.1038/nature05907 ID - Borg2007 ER - TY - JOUR AU - Pellicci, D. G. PY - 2009 DA - 2009// TI - Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors JO - Immunity VL - 31 UR - https://doi.org/10.1016/j.immuni.2009.04.018 DO - 10.1016/j.immuni.2009.04.018 ID - Pellicci2009 ER - TY - JOUR AU - Miyamoto, K. AU - Miyake, S. AU - Yamamura, T. PY - 2001 DA - 2001// TI - A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells JO - Nature VL - 413 UR - https://doi.org/10.1038/35097097 DO - 10.1038/35097097 ID - Miyamoto2001 ER - TY - JOUR AU - Schmieg, J. PY - 2003 DA - 2003// TI - Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide JO - J Exp Med VL - 198 UR - https://doi.org/10.1084/jem.20031192 DO - 10.1084/jem.20031192 ID - Schmieg2003 ER - TY - JOUR AU - Chang, Y. J. PY - 2007 DA - 2007// TI - Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids JO - Proc Natl Acad Sci U S A VL - 104 UR - https://doi.org/10.1073/pnas.0703824104 DO - 10.1073/pnas.0703824104 ID - Chang2007 ER - TY - JOUR AU - Hung, J. T. PY - 2014 DA - 2014// TI - Potent adjuvant effects of novel NKT stimulatory glycolipids on hemagglutinin based DNA vaccine for H5N1 influenza virus JO - Antiviral Res VL - 107 UR - https://doi.org/10.1016/j.antiviral.2014.04.007 DO - 10.1016/j.antiviral.2014.04.007 ID - Hung2014 ER - TY - JOUR AU - Renukaradhya, G. J. PY - 2008 DA - 2008// TI - Type I NKT cells protect (and type II NKT cells suppress) the host’s innate antitumor immune response to a B-cell lymphoma JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-05-092866 DO - 10.1182/blood-2007-05-092866 ID - Renukaradhya2008 ER - TY - JOUR AU - Lantz, O. AU - Bendelac, A. PY - 1994 DA - 1994// TI - An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4−8- T cells in mice and humans JO - J Exp Med VL - 180 UR - https://doi.org/10.1084/jem.180.3.1097 DO - 10.1084/jem.180.3.1097 ID - Lantz1994 ER - TY - JOUR AU - Ohteki, T. AU - MacDonald, H. R. PY - 1996 DA - 1996// TI - Stringent V beta requirement for the development of NK1.1+ T cell receptor-alpha/beta + cells in mouse liver JO - J Exp Med VL - 183 UR - https://doi.org/10.1084/jem.183.3.1277 DO - 10.1084/jem.183.3.1277 ID - Ohteki1996 ER - TY - JOUR AU - Arase, H. PY - 1992 DA - 1992// TI - An NK1.1+ CD4+8- single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family JO - Proc Natl Acad Sci U S A VL - 89 UR - https://doi.org/10.1073/pnas.89.14.6506 DO - 10.1073/pnas.89.14.6506 ID - Arase1992 ER - TY - JOUR AU - Ohteki, T. AU - MacDonald, H. R. PY - 1994 DA - 1994// TI - Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4−8- subsets of natural killer 1.1+ T cell receptor-alpha/beta + cells in the liver of mice JO - J Exp Med VL - 180 UR - https://doi.org/10.1084/jem.180.2.699 DO - 10.1084/jem.180.2.699 ID - Ohteki1994 ER - TY - JOUR AU - MacDonald, H. R. PY - 1995 DA - 1995// TI - NK1.1+ T cell receptor-alpha/beta + cells: new clues to their origin, specificity, and function JO - J Exp Med VL - 182 UR - https://doi.org/10.1084/jem.182.3.633 DO - 10.1084/jem.182.3.633 ID - MacDonald1995 ER - TY - JOUR AU - Bendelac, A. PY - 1997 DA - 1997// TI - Mouse CD1-specific NK1 T cells: development, specificity, and function JO - Annu Rev Immunol VL - 15 UR - https://doi.org/10.1146/annurev.immunol.15.1.535 DO - 10.1146/annurev.immunol.15.1.535 ID - Bendelac1997 ER - TY - JOUR AU - Dellabona, P. PY - 1994 DA - 1994// TI - An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4−8- T cells JO - J Exp Med VL - 180 UR - https://doi.org/10.1084/jem.180.3.1171 DO - 10.1084/jem.180.3.1171 ID - Dellabona1994 ER - TY - JOUR AU - Porcelli, S. PY - 1993 DA - 1993// TI - Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4−8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain JO - J Exp Med VL - 178 UR - https://doi.org/10.1084/jem.178.1.1 DO - 10.1084/jem.178.1.1 ID - Porcelli1993 ER - TY - JOUR AU - Liao, C. M. AU - Zimmer, M. I. AU - Wang, C. R. PY - 2013 DA - 2013// TI - The functions of type I and type II natural killer T cells in inflammatory bowel diseases JO - Inflamm Bowel Dis VL - 19 UR - https://doi.org/10.1097/MIB.0b013e318280b1e3 DO - 10.1097/MIB.0b013e318280b1e3 ID - Liao2013 ER - TY - JOUR AU - Brossay, L. PY - 1998 DA - 1998// TI - CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution JO - J Exp Med VL - 188 UR - https://doi.org/10.1084/jem.188.8.1521 DO - 10.1084/jem.188.8.1521 ID - Brossay1998 ER - TY - JOUR AU - Kawano, T. PY - 1997 DA - 1997// TI - CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides JO - Science VL - 278 UR - https://doi.org/10.1126/science.278.5343.1626 DO - 10.1126/science.278.5343.1626 ID - Kawano1997 ER - TY - JOUR AU - Spada, F. M. AU - Koezuka, Y. AU - Porcelli, S. A. PY - 1998 DA - 1998// TI - CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells JO - J Exp Med VL - 188 UR - https://doi.org/10.1084/jem.188.8.1529 DO - 10.1084/jem.188.8.1529 ID - Spada1998 ER - TY - JOUR AU - Brossay, L. PY - 1997 DA - 1997// TI - Mouse CD1 is mainly expressed on hemopoietic-derived cells JO - J Immunol VL - 159 ID - Brossay1997 ER - TY - JOUR AU - Koch, M. PY - 2005 DA - 2005// TI - The crystal structure of human CD1d with and without alpha-galactosylceramide JO - Nat Immunol VL - 6 UR - https://doi.org/10.1038/ni1225 DO - 10.1038/ni1225 ID - Koch2005 ER - TY - JOUR AU - Zeng, Z. PY - 1997 DA - 1997// TI - Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove JO - Science VL - 277 UR - https://doi.org/10.1126/science.277.5324.339 DO - 10.1126/science.277.5324.339 ID - Zeng1997 ER - TY - JOUR AU - Zajonc, D. M. PY - 2005 DA - 2005// TI - Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity JO - J Exp Med VL - 202 UR - https://doi.org/10.1084/jem.20051625 DO - 10.1084/jem.20051625 ID - Zajonc2005 ER - TY - JOUR AU - Zajonc, D. M. PY - 2005 DA - 2005// TI - Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor JO - Nat Immunol VL - 6 UR - https://doi.org/10.1038/ni1224 DO - 10.1038/ni1224 ID - Zajonc2005 ER - TY - JOUR AU - Giabbai, B. PY - 2005 DA - 2005// TI - Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: a molecular basis for NKT cell activation JO - J Immunol VL - 175 UR - https://doi.org/10.4049/jimmunol.175.2.977 DO - 10.4049/jimmunol.175.2.977 ID - Giabbai2005 ER - TY - JOUR AU - Zajonc, D. M. PY - 2006 DA - 2006// TI - Structural characterization of mycobacterial phosphatidylinositol mannoside binding to mouse CD1d JO - J Immunol VL - 177 UR - https://doi.org/10.4049/jimmunol.177.7.4577 DO - 10.4049/jimmunol.177.7.4577 ID - Zajonc2006 ER - TY - JOUR AU - Moody, D. B. AU - Zajonc, D. M. AU - Wilson, I. A. PY - 2005 DA - 2005// TI - Anatomy of CD1-lipid antigen complexes JO - Nat Rev Immunol VL - 5 UR - https://doi.org/10.1038/nri1605 DO - 10.1038/nri1605 ID - Moody2005 ER - TY - JOUR AU - Matsuda, J. L. PY - 2000 DA - 2000// TI - Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers JO - J Exp Med VL - 192 UR - https://doi.org/10.1084/jem.192.5.741 DO - 10.1084/jem.192.5.741 ID - Matsuda2000 ER - TY - JOUR AU - Hong, S. PY - 1999 DA - 1999// TI - Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice JO - Immunol Rev VL - 169 UR - https://doi.org/10.1111/j.1600-065X.1999.tb01304.x DO - 10.1111/j.1600-065X.1999.tb01304.x ID - Hong1999 ER - TY - JOUR AU - Burdin, N. PY - 1998 DA - 1998// TI - Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes JO - J Immunol VL - 161 ID - Burdin1998 ER - TY - JOUR AU - Stetson, D. B. PY - 2003 DA - 2003// TI - Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function JO - J Exp Med VL - 198 UR - https://doi.org/10.1084/jem.20030630 DO - 10.1084/jem.20030630 ID - Stetson2003 ER - TY - JOUR AU - Carnaud, C. PY - 1999 DA - 1999// TI - Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells JO - J Immunol VL - 163 ID - Carnaud1999 ER - TY - JOUR AU - Fujii, S. PY - 2003 DA - 2003// TI - Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein JO - J Exp Med VL - 198 UR - https://doi.org/10.1084/jem.20030324 DO - 10.1084/jem.20030324 ID - Fujii2003 ER - TY - JOUR AU - Denkers, E. Y. PY - 1996 DA - 1996// TI - A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection JO - J Exp Med VL - 184 UR - https://doi.org/10.1084/jem.184.1.131 DO - 10.1084/jem.184.1.131 ID - Denkers1996 ER - TY - JOUR AU - Apostolou, I. PY - 1999 DA - 1999// TI - Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls JO - Proc Natl Acad Sci U S A VL - 96 UR - https://doi.org/10.1073/pnas.96.9.5141 DO - 10.1073/pnas.96.9.5141 ID - Apostolou1999 ER - TY - JOUR AU - Kakimi, K. PY - 2000 DA - 2000// TI - Natural killer T cell activation inhibits hepatitis B virus replication in vivo JO - J Exp Med VL - 192 UR - https://doi.org/10.1084/jem.192.7.921 DO - 10.1084/jem.192.7.921 ID - Kakimi2000 ER - TY - JOUR AU - Rissoan, M. C. PY - 1999 DA - 1999// TI - Reciprocal control of T helper cell and dendritic cell differentiation JO - Science VL - 283 UR - https://doi.org/10.1126/science.283.5405.1183 DO - 10.1126/science.283.5405.1183 ID - Rissoan1999 ER - TY - JOUR AU - Arrenberg, P. PY - 2010 DA - 2010// TI - Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid JO - Proc Natl Acad Sci U S A VL - 107 UR - https://doi.org/10.1073/pnas.1000576107 DO - 10.1073/pnas.1000576107 ID - Arrenberg2010 ER - TY - JOUR AU - Girardi, E. PY - 2012 DA - 2012// TI - Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens JO - Nat Immunol VL - 13 UR - https://doi.org/10.1038/ni.2371 DO - 10.1038/ni.2371 ID - Girardi2012 ER - TY - JOUR AU - Halder, R. C. PY - 2007 DA - 2007// TI - Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease JO - J Clin Invest VL - 117 UR - https://doi.org/10.1172/JCI31602 DO - 10.1172/JCI31602 ID - Halder2007 ER - TY - JOUR AU - Oh, S. J. PY - 2008 DA - 2008// TI - Role of type II NKT cells in the suppression of graft-versus-host disease JO - Crit Rev Immunol VL - 28 UR - https://doi.org/10.1615/CritRevImmunol.v28.i3.50 DO - 10.1615/CritRevImmunol.v28.i3.50 ID - Oh2008 ER - TY - JOUR AU - Zhang, G. PY - 2011 DA - 2011// TI - Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell function in a mouse model of asthma JO - Am J Physiol Lung Cell Mol Physiol VL - 301 UR - https://doi.org/10.1152/ajplung.00114.2011 DO - 10.1152/ajplung.00114.2011 ID - Zhang2011 ER - TY - JOUR AU - Ambrosino, E. PY - 2007 DA - 2007// TI - Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis JO - J Immunol VL - 179 UR - https://doi.org/10.4049/jimmunol.179.8.5126 DO - 10.4049/jimmunol.179.8.5126 ID - Ambrosino2007 ER - TY - JOUR AU - Chang, D. H. PY - 2008 DA - 2008// TI - Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer JO - Blood VL - 112 UR - https://doi.org/10.1182/blood-2008-04-149831 DO - 10.1182/blood-2008-04-149831 ID - Chang2008 ER - TY - JOUR AU - Hix, L. M. PY - 2011 DA - 2011// TI - CD1d-expressing breast cancer cells modulate NKT cell-mediated antitumor immunity in a murine model of breast cancer metastasis JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0020702 DO - 10.1371/journal.pone.0020702 ID - Hix2011 ER - TY - JOUR AU - Izhak, L. PY - 2013 DA - 2013// TI - Delicate balance among three types of T cells in concurrent regulation of tumor immunity JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-2567 DO - 10.1158/0008-5472.CAN-12-2567 ID - Izhak2013 ER - TY - JOUR AU - Kobayashi, E. PY - 1995 DA - 1995// TI - KRN7000, a novel immunomodulator, and its antitumor activities JO - Oncol Res VL - 7 ID - Kobayashi1995 ER - TY - JOUR AU - Natori, T. AU - Koezuka, Y. AU - Higa, T. PY - 1993 DA - 1993// TI - Agelasphins, novel α-galactosylceramides from the marine sponge Agelas mauritianus JO - Tetrahedron Lett VL - 34 UR - https://doi.org/10.1016/S0040-4039(00)73889-5 DO - 10.1016/S0040-4039(00)73889-5 ID - Natori1993 ER - TY - JOUR AU - Morita, M. PY - 1995 DA - 1995// TI - Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice JO - J Med Chem VL - 38 UR - https://doi.org/10.1021/jm00012a018 DO - 10.1021/jm00012a018 ID - Morita1995 ER - TY - JOUR AU - Mizuno, M. PY - 2004 DA - 2004// TI - Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice JO - J Autoimmun VL - 23 UR - https://doi.org/10.1016/j.jaut.2004.09.008 DO - 10.1016/j.jaut.2004.09.008 ID - Mizuno2004 ER - TY - JOUR AU - Savage, P. B. AU - Teyton, L. AU - Bendelac, A. PY - 2006 DA - 2006// TI - Glycolipids for natural killer T cells JO - Chem Soc Rev VL - 35 UR - https://doi.org/10.1039/b510638a DO - 10.1039/b510638a ID - Savage2006 ER - TY - JOUR AU - Wu, D. AU - Fujio, M. AU - Wong, C. H. PY - 2008 DA - 2008// TI - Glycolipids as immunostimulating agents JO - Bioorg Med Chem VL - 16 UR - https://doi.org/10.1016/j.bmc.2007.10.026 DO - 10.1016/j.bmc.2007.10.026 ID - Wu2008 ER - TY - JOUR AU - McCarthy, C. PY - 2007 DA - 2007// TI - The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation JO - J Exp Med VL - 204 UR - https://doi.org/10.1084/jem.20062342 DO - 10.1084/jem.20062342 ID - McCarthy2007 ER - TY - JOUR AU - Oki, S. PY - 2004 DA - 2004// TI - The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells JO - J Clin Invest VL - 113 UR - https://doi.org/10.1172/JCI200420862 DO - 10.1172/JCI200420862 ID - Oki2004 ER - TY - JOUR AU - Wu, T. N. PY - 2011 DA - 2011// TI - Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy JO - Proc Natl Acad Sci U S A VL - 108 UR - https://doi.org/10.1073/pnas.1114255108 DO - 10.1073/pnas.1114255108 ID - Wu2011 ER - TY - JOUR AU - Tashiro, T. PY - 2008 DA - 2008// TI - RCAI-17, 22, 24–26, 29, 31, 34–36, 38–40, and 88, the analogs of KRN7000 with a sulfonamide linkage: their synthesis and bioactivity for mouse natural killer T cells to produce Th2-biased cytokines JO - Bioorg Med Chem VL - 16 UR - https://doi.org/10.1016/j.bmc.2008.08.060 DO - 10.1016/j.bmc.2008.08.060 ID - Tashiro2008 ER - TY - JOUR AU - Padte, N. N. PY - 2013 DA - 2013// TI - A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0078407 DO - 10.1371/journal.pone.0078407 ID - Padte2013 ER - TY - STD TI - Wu TA, et al. Phenyl Glycolipids with Different Glycosyl Groups Exhibit Marked Differences in Murine and Human iNKT Cell Activation. ACS Chem Biol. 2016. in press. ID - ref63 ER - TY - JOUR AU - Huang, J. R. PY - 2014 DA - 2014// TI - alpha-Galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2/3 JO - J Immunol VL - 192 UR - https://doi.org/10.4049/jimmunol.1302623 DO - 10.4049/jimmunol.1302623 ID - Huang2014 ER - TY - JOUR AU - Raju, R. PY - 2009 DA - 2009// TI - Synthesis and evaluation of 3″- and 4″-deoxy and -fluoro analogs of the immunostimulatory glycolipid, KRN7000 JO - Bioorg Med Chem Lett VL - 19 UR - https://doi.org/10.1016/j.bmcl.2009.06.005 DO - 10.1016/j.bmcl.2009.06.005 ID - Raju2009 ER - TY - JOUR AU - Prigozy, T. I. PY - 2001 DA - 2001// TI - Glycolipid antigen processing for presentation by CD1d molecules JO - Science VL - 291 UR - https://doi.org/10.1126/science.291.5504.664 DO - 10.1126/science.291.5504.664 ID - Prigozy2001 ER - TY - JOUR AU - Zhou, X. T. PY - 2002 DA - 2002// TI - Synthesis and NKT cell stimulating properties of fluorophore- and biotin-appended 6″-amino-6″-deoxy-galactosylceramides JO - Org Lett VL - 4 UR - https://doi.org/10.1021/ol025565+ DO - 10.1021/ol025565+ ID - Zhou2002 ER - TY - JOUR AU - Ebensen, T. PY - 2007 DA - 2007// TI - A pegylated derivative of alpha-galactosylceramide exhibits improved biological properties JO - J Immunol VL - 179 UR - https://doi.org/10.4049/jimmunol.179.4.2065 DO - 10.4049/jimmunol.179.4.2065 ID - Ebensen2007 ER - TY - JOUR AU - Aspeslagh, S. PY - 2011 DA - 2011// TI - Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis JO - EMBO J VL - 30 UR - https://doi.org/10.1038/emboj.2011.145 DO - 10.1038/emboj.2011.145 ID - Aspeslagh2011 ER - TY - JOUR AU - Pauwels, N. PY - 2011 DA - 2011// TI - Divergent synthetic approach to 6″-modified alpha-GalCer analogues JO - Org Biomol Chem VL - 9 UR - https://doi.org/10.1039/c1ob06235b DO - 10.1039/c1ob06235b ID - Pauwels2011 ER - TY - JOUR AU - Hsieh, M. H. PY - 2012 DA - 2012// TI - Synthesis and evaluation of acyl-chain- and galactose-6″-modified analogues of alpha-GalCer for NKT cell activation JO - Chembiochem VL - 13 UR - https://doi.org/10.1002/cbic.201200004 DO - 10.1002/cbic.201200004 ID - Hsieh2012 ER - TY - JOUR AU - Hung, J. -. T. PY - 2014 DA - 2014// TI - Design and synthesis of galactose-6-OH-modified [small alpha]-galactosyl ceramide analogues with Th2-biased immune responses JO - RSC Adv VL - 4 UR - https://doi.org/10.1039/C4RA08602C DO - 10.1039/C4RA08602C ID - Hung2014 ER - TY - JOUR AU - Aspeslagh, S. PY - 2013 DA - 2013// TI - Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection JO - J Immunol VL - 191 UR - https://doi.org/10.4049/jimmunol.1203134 DO - 10.4049/jimmunol.1203134 ID - Aspeslagh2013 ER - TY - JOUR AU - Park, J. J. PY - 2008 DA - 2008// TI - Synthesis of all stereoisomers of KRN7000, the CD1d-binding NKT cell ligand JO - Bioorg Med Chem Lett VL - 18 UR - https://doi.org/10.1016/j.bmcl.2008.06.036 DO - 10.1016/j.bmcl.2008.06.036 ID - Park2008 ER - TY - JOUR AU - Fuhshuku, K. PY - 2008 DA - 2008// TI - RCAI-8, 9, 18, 19, and 49–52, conformationally restricted analogues of KRN7000 with an azetidine or a pyrrolidine ring: Their synthesis and bioactivity for mouse natural killer T cells to produce cytokines JO - Bioorg Med Chem VL - 16 UR - https://doi.org/10.1016/j.bmc.2007.10.008 DO - 10.1016/j.bmc.2007.10.008 ID - Fuhshuku2008 ER - TY - JOUR AU - Shiozaki, M. PY - 2010 DA - 2010// TI - Synthesis and biological activity of ester and ether analogues of alpha-galactosylceramide (KRN7000) JO - Carbohydr Res VL - 345 UR - https://doi.org/10.1016/j.carres.2010.05.003 DO - 10.1016/j.carres.2010.05.003 ID - Shiozaki2010 ER - TY - JOUR AU - Birkholz, A. M. PY - 2015 DA - 2015// TI - A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-gamma Production JO - J Immunol VL - 195 UR - https://doi.org/10.4049/jimmunol.1500070 DO - 10.4049/jimmunol.1500070 ID - Birkholz2015 ER - TY - JOUR AU - Li, X. PY - 2009 DA - 2009// TI - Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells JO - Immunology VL - 127 UR - https://doi.org/10.1111/j.1365-2567.2008.02943.x DO - 10.1111/j.1365-2567.2008.02943.x ID - Li2009 ER - TY - JOUR AU - Giaccone, G. PY - 2002 DA - 2002// TI - A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors JO - Clin Cancer Res VL - 8 ID - Giaccone2002 ER - TY - JOUR AU - Crough, T. PY - 2004 DA - 2004// TI - Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies JO - Br J Cancer VL - 91 UR - https://doi.org/10.1038/sj.bjc.6602218 DO - 10.1038/sj.bjc.6602218 ID - Crough2004 ER - TY - JOUR AU - Toura, I. PY - 1999 DA - 1999// TI - Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide JO - J Immunol VL - 163 ID - Toura1999 ER - TY - JOUR AU - Vliet, H. J. PY - 2001 DA - 2001// TI - Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15 JO - J Immunol Methods VL - 247 UR - https://doi.org/10.1016/S0022-1759(00)00272-6 DO - 10.1016/S0022-1759(00)00272-6 ID - Vliet2001 ER - TY - JOUR AU - Fujii, S. PY - 2002 DA - 2002// TI - Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs JO - Nat Immunol VL - 3 UR - https://doi.org/10.1038/ni827 DO - 10.1038/ni827 ID - Fujii2002 ER - TY - JOUR AU - Nieda, M. PY - 2004 DA - 2004// TI - Therapeutic activation of Valpha24 + Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity JO - Blood VL - 103 UR - https://doi.org/10.1182/blood-2003-04-1155 DO - 10.1182/blood-2003-04-1155 ID - Nieda2004 ER - TY - JOUR AU - Chang, D. H. PY - 2005 DA - 2005// TI - Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients JO - J Exp Med VL - 201 UR - https://doi.org/10.1084/jem.20042592 DO - 10.1084/jem.20042592 ID - Chang2005 ER - TY - JOUR AU - Uchida, T. PY - 2008 DA - 2008// TI - Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer JO - Cancer Immunol Immunother VL - 57 UR - https://doi.org/10.1007/s00262-007-0373-5 DO - 10.1007/s00262-007-0373-5 ID - Uchida2008 ER - TY - JOUR AU - Kunii, N. PY - 2009 DA - 2009// TI - Combination therapy of in vitro-expanded natural killer T cells and alpha-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma JO - Cancer Sci VL - 100 UR - https://doi.org/10.1111/j.1349-7006.2009.01135.x DO - 10.1111/j.1349-7006.2009.01135.x ID - Kunii2009 ER - TY - JOUR AU - Nicol, A. J. AU - Tazbirkova, A. AU - Nieda, M. PY - 2011 DA - 2011// TI - Comparison of clinical and immunological effects of intravenous and intradermal administration of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-3105 DO - 10.1158/1078-0432.CCR-10-3105 ID - Nicol2011 ER - TY - JOUR AU - Veldt, B. J. PY - 2007 DA - 2007// TI - Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C JO - J Hepatol VL - 47 UR - https://doi.org/10.1016/j.jhep.2007.04.018 DO - 10.1016/j.jhep.2007.04.018 ID - Veldt2007 ER - TY - JOUR AU - Woltman, A. M. PY - 2009 DA - 2009// TI - Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial JO - Antivir Ther VL - 14 UR - https://doi.org/10.3851/IMP1295 DO - 10.3851/IMP1295 ID - Woltman2009 ER - TY - JOUR AU - Osman, Y. PY - 2000 DA - 2000// TI - Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide JO - Eur J Immunol VL - 30 UR - https://doi.org/3.0.CO;2-3 DO - 3.0.CO;2-3 ID - Osman2000 ER - TY - JOUR AU - Sullivan, B. A. AU - Kronenberg, M. PY - 2005 DA - 2005// TI - Activation or anergy: NKT cells are stunned by alpha-galactosylceramide JO - J Clin Invest VL - 115 UR - https://doi.org/10.1172/JCI26297 DO - 10.1172/JCI26297 ID - Sullivan2005 ER - TY - JOUR AU - Parekh, V. V. PY - 2005 DA - 2005// TI - Glycolipid antigen induces long-term natural killer T cell anergy in mice JO - J Clin Invest VL - 115 UR - https://doi.org/10.1172/JCI24762 DO - 10.1172/JCI24762 ID - Parekh2005 ER - TY - JOUR AU - Zheng, Y. AU - Zha, Y. AU - Gajewski, T. F. PY - 2008 DA - 2008// TI - Molecular regulation of T-cell anergy JO - EMBO Rep VL - 9 UR - https://doi.org/10.1038/sj.embor.7401138 DO - 10.1038/sj.embor.7401138 ID - Zheng2008 ER - TY - JOUR AU - Dugast, A. S. PY - 2008 DA - 2008// TI - Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion JO - J Immunol VL - 180 UR - https://doi.org/10.4049/jimmunol.180.12.7898 DO - 10.4049/jimmunol.180.12.7898 ID - Dugast2008 ER - TY - JOUR AU - Hanson, E. M. PY - 2009 DA - 2009// TI - Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells JO - J Immunol VL - 183 UR - https://doi.org/10.4049/jimmunol.0804253 DO - 10.4049/jimmunol.0804253 ID - Hanson2009 ER - TY - JOUR AU - Moline-Velazquez, V. PY - 2011 DA - 2011// TI - Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis JO - Brain Pathol VL - 21 UR - https://doi.org/10.1111/j.1750-3639.2011.00495.x DO - 10.1111/j.1750-3639.2011.00495.x ID - Moline-Velazquez2011 ER - TY - JOUR AU - Li, H. PY - 2009 DA - 2009// TI - Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1 JO - J Immunol VL - 182 UR - https://doi.org/10.4049/jimmunol.182.1.240 DO - 10.4049/jimmunol.182.1.240 ID - Li2009 ER - TY - JOUR AU - Bunt, S. K. PY - 2006 DA - 2006// TI - Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression JO - J Immunol VL - 176 UR - https://doi.org/10.4049/jimmunol.176.1.284 DO - 10.4049/jimmunol.176.1.284 ID - Bunt2006 ER - TY - JOUR AU - Sinha, P. AU - Clements, V. K. AU - Ostrand-Rosenberg, S. PY - 2005 DA - 2005// TI - Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease JO - J Immunol VL - 174 UR - https://doi.org/10.4049/jimmunol.174.2.636 DO - 10.4049/jimmunol.174.2.636 ID - Sinha2005 ER - TY - JOUR AU - Rodriguez, P. C. AU - Ochoa, A. C. PY - 2008 DA - 2008// TI - Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives JO - Immunol Rev VL - 222 UR - https://doi.org/10.1111/j.1600-065X.2008.00608.x DO - 10.1111/j.1600-065X.2008.00608.x ID - Rodriguez2008 ER - TY - JOUR AU - Ochoa, A. C. PY - 2007 DA - 2007// TI - Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2197 DO - 10.1158/1078-0432.CCR-06-2197 ID - Ochoa2007 ER - TY - JOUR AU - Ito, H. AU - Ando, T. AU - Seishima, M. PY - 2015 DA - 2015// TI - Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model JO - Oncotarget VL - 6 ID - Ito2015 ER -